MusclePharm Stock Forecast, Price & News

MusclePharm (OTCMKTS:MSLP) Frequently Asked Questions

How has MusclePharm's stock price been impacted by Coronavirus?

MusclePharm's stock was trading at $0.18 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MSLP shares have increased by 150.0% and is now trading at $0.45.
View which stocks have been most impacted by COVID-19.

Are investors shorting MusclePharm?

MusclePharm saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 7,300 shares, an increase of 812.5% from the October 31st total of 800 shares. Based on an average trading volume of 21,900 shares, the days-to-cover ratio is presently 0.3 days.
View MusclePharm's Short Interest.

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings results on Monday, November, 15th. The company reported ($0.12) EPS for the quarter. The company had revenue of $11.97 million for the quarter. MusclePharm had a negative net margin of 5.93% and a negative trailing twelve-month return on equity of 5.24%.
View MusclePharm's earnings history.

Who are MusclePharm's key executives?

MusclePharm's management team includes the following people:

• Ryan Charles Drexler, Executive Chairman & Chief Executive Officer
• Sabina Rizvi, President & Chief Financial Officer

Who are some of MusclePharm's key competitors?

Some companies that are related to MusclePharm include Biophytis (BPTS), VYNE Therapeutics (VYNE), Galmed Pharmaceuticals (GLMD), Onconova Therapeutics (ONTX), Vicapsys Life Sciences (VICP), Spruce Biosciences (SPRB), Synaptogenix (SNPX), Lotus Pharmaceuticals (LTUS), Tempest Therapeutics (TPST), Moleculin Biotech (MBRX), Aptorum Group (APM), Aravive (ARAV), Calithera Biosciences (CALA), Lumos Pharma (LUMO) and Celsion (CLSN).
View all of MSLP's competitors.

What other stocks do shareholders of MusclePharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MusclePharm investors own include Dalradian Resources (DALR), EVRAZ (EVRZF), Rent-A-Center (RCII), Avino Silver & Gold Mines (ASM), AdvanSix (ASIX), Accuray (ARAY), Apollo Global Management (APO), TD Ameritrade (AMTD), Alaska Communications Systems Group (ALSK) and Alnylam Pharmaceuticals (ALNY).

What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How do I buy shares of MusclePharm?

Shares of MSLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.45.

How much money does MusclePharm make?

MusclePharm has a market capitalization of $15.46 million and generates $64.44 million in revenue each year. The company earns $3.18 million in net income (profit) each year or ($0.13) on an earnings per share basis.

How many employees does MusclePharm have?

MusclePharm employs 27 workers across the globe.

What is MusclePharm's official website?

The official website for MusclePharm is www.musclepharm.com.

Where are MusclePharm's headquarters?

MusclePharm is headquartered at 4400 VANOWEN STREET, BURBANK CA, 80239.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The company can be reached via phone at (800) 292-3909 or via email at [email protected].